Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Ellmark

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Cancer Letters|May 15, 2004
Profiling of internalizing tumor-associated antigens on breast and pancreatic cancer cells by reversed genomicsJohan Fransson, Sara Ek, Peter Ellmark, et al.
Molecular & Cellular Proteomics : MCP|July 18, 2006
Identification of protein expression signatures associated with Helicobacter pylori infection and gastric adenocarcinoma using recombinant antibody microarraysPeter Ellmark, Johan Ingvarsson, Anders Carlsson, et al.
Expert Opinion on Biological Therapy|May 20, 2024
Next-generation CD40 agonists for cancer immunotherapyHampus Andersson, Barnabas Nyesiga, Tova Hermodsson, et al.
Oncoimmunology|April 5, 2014
Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivoLinda C Sandin, Fredrik Eriksson, Peter Ellmark, et al.
Journal for Immunotherapy of Cancer|January 23, 2025
First-in-human, multicenter, open-label, phase I study of ATOR-1017 (evunzekibart), a 4-1BB antibody, in patients with advanced solid malignanciesAna Carneiro, Amanda Hahn, Peter Ellmark, et al.
Cancer Immunology Research|April 30, 2014
Locally delivered CD40 agonist antibody accumulates in secondary lymphoid organs and eradicates experimental disseminated bladder cancerLinda C Sandin, Anna Orlova, Erika Gustafsson, et al.
Proteomics|October 3, 2009
Attovial-based antibody nanoarraysPeter Ellmark, Sara Ghatnekar-Nilsson, André Meister, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2008
Serum proteome profiling of metastatic breast cancer using recombinant antibody microarraysAnders Carlsson, Christer Wingren, Johan Ingvarsson, et al.
AIDS Research and Human Retroviruses|April 1, 2008
Sensitivity of HIV type 1 primary isolates to human anti-CD40 antibody-mediated suppression is related to coreceptor useSisay A Abayneh, Peter Ellmark, Ulf Karlsson, et al.
Proteomics|February 18, 2006
Multiplex detection of surface molecules on colorectal cancersPeter Ellmark, Larissa Belov, Pauline Huang, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Cancer Letters|May 15, 2004
Profiling of internalizing tumor-associated antigens on breast and pancreatic cancer cells by reversed genomicsJohan Fransson, Sara Ek, Peter Ellmark, et al.
Molecular & Cellular Proteomics : MCP|July 18, 2006
Identification of protein expression signatures associated with Helicobacter pylori infection and gastric adenocarcinoma using recombinant antibody microarraysPeter Ellmark, Johan Ingvarsson, Anders Carlsson, et al.
Expert Opinion on Biological Therapy|May 20, 2024
Next-generation CD40 agonists for cancer immunotherapyHampus Andersson, Barnabas Nyesiga, Tova Hermodsson, et al.
Oncoimmunology|April 5, 2014
Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivoLinda C Sandin, Fredrik Eriksson, Peter Ellmark, et al.
Journal for Immunotherapy of Cancer|January 23, 2025
First-in-human, multicenter, open-label, phase I study of ATOR-1017 (evunzekibart), a 4-1BB antibody, in patients with advanced solid malignanciesAna Carneiro, Amanda Hahn, Peter Ellmark, et al.
Cancer Immunology Research|April 30, 2014
Locally delivered CD40 agonist antibody accumulates in secondary lymphoid organs and eradicates experimental disseminated bladder cancerLinda C Sandin, Anna Orlova, Erika Gustafsson, et al.
Proteomics|October 3, 2009
Attovial-based antibody nanoarraysPeter Ellmark, Sara Ghatnekar-Nilsson, André Meister, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2008
Serum proteome profiling of metastatic breast cancer using recombinant antibody microarraysAnders Carlsson, Christer Wingren, Johan Ingvarsson, et al.
AIDS Research and Human Retroviruses|April 1, 2008
Sensitivity of HIV type 1 primary isolates to human anti-CD40 antibody-mediated suppression is related to coreceptor useSisay A Abayneh, Peter Ellmark, Ulf Karlsson, et al.
Proteomics|February 18, 2006
Multiplex detection of surface molecules on colorectal cancersPeter Ellmark, Larissa Belov, Pauline Huang, et al.
Pageof 4